Status:
COMPLETED
Multicenter Myocardial Viability Trial
Lead Sponsor:
CHI St. Luke's Health, Texas
Collaborating Sponsors:
Medtronic - MITG
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
21-85 years
Brief Summary
The purpose of this study is to test the hypothesis of whether contrast enhanced Magnetic Resonance Imaging can be used to predict improvement of the wall motion in regions of the heart with abnormal ...
Eligibility Criteria
Inclusion
- Age: \> 21 years and \< 85 years
- Sinus rhythm
- Weight \< 120 kg
- LVEF \> 30%
- Wall motion abnormality on Echo. or LV-gram
- Scheduled for revascularization - Angioplasty/Stent or CABG - within 30 days
Exclusion
- Resting heart rate \> 100 bpm
- Frequent atrial or ventricular ectopy
- Severe aortic stenosis or HOCM
- Unstable angina
- Myocardial infarction within 14 days
- Active congestive heart failure
- Pregnancy
- Known allergy to gadolinium
- Contraindication to MRI
Key Trial Info
Start Date :
August 11 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2011
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT00661232
Start Date
August 11 2003
End Date
May 15 2011
Last Update
December 2 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Luke's Episcopal Hospital
Houston, Texas, United States, 77030
2
St. Luke's Episcopal Location
Houston, Texas, United States, 77030
3
Cliniques Universitaires St. Luc
Brussels, Belgium, B-1200
4
Skejby University Hospital
Aarhus N, Denmark, 8200